Cargando…

Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin

Periprosthetic osteolysis belongs to osteolytic diseases, which often occur due to an imbalance between osteoclast and osteoblast number or activity. Fraxetin, a natural plant extract, inhibits osteoblast apoptosis and has therapeutic potential for treating osteolytic diseases. However, data pertain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Jia-Cheng, Wei, Zhao-Xia, Zhao, Chang, Ma, Zhong-Ping, Cai, Dao-Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089765/ https://www.ncbi.nlm.nih.gov/pubmed/29786751 http://dx.doi.org/10.3892/ijmm.2018.3698

Ejemplares similares

Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways
por: Hu, Xuantao, et al.
Publicado: (2020)

Cimifugin Suppresses NF-κB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis
por: Duan, Juan, et al.
Publicado: (2021)

The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis
por: Wang, Wengang, et al.
Publicado: (2014)

Pyroptosis in Periprosthetic Osteolysis
por: Yin, Jian, et al.
Publicado: (2022)

Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis
por: Huang, Linke, et al.
Publicado: (2022)

Britanin inhibits titanium wear particle‑induced osteolysis and osteoclastogenesis
por: Kim, Ju Ang, et al.
Publicado: (2023)

Inhibition of RANKL- induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium- particle- induced osteolysis
Publicado: (2018)

Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment
por: Goodman, Stuart B., et al.
Publicado: (2019)

The dual role of autophagy in periprosthetic osteolysis
por: Yin, Zhaoyang, et al.
Publicado: (2023)

Forsythiaside inhibited titanium particle-induced inflammation via the NF-κB signaling pathway and RANKL-induced osteoclastogenesis and titanium particle-induced periprosthetic osteolysis via JNK, p38, and ERK signaling pathways
por: Xu, Kaihang, et al.
Publicado: (2019)

SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis
por: Gu, Minghui, et al.
Publicado: (2022)

Puerarin inhibits titanium particle‐induced osteolysis and RANKL‐induced osteoclastogenesis via suppression of the NF‐κB signaling pathway
por: Tang, Wenkai, et al.
Publicado: (2020)

Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway
por: Chen, Yueqi, et al.
Publicado: (2020)

Astragalus polysaccharide attenuates LPS‐related inflammatory osteolysis by suppressing osteoclastogenesis by reducing the MAPK signalling pathway
por: Yang, Jianye, et al.
Publicado: (2021)

Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade
por: Zhang, Liwei, et al.
Publicado: (2020)

Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling in vitro and suppresses LPS-induced osteolysis and ovariectomy-induced osteoporosis in vivo : Methyl 3,4-dihydroxybenzoate inhibits osteoclastogenesis
por: Huang, Zhaobo, et al.
Publicado: (2022)

Stevioside Prevents Wear Particle-Induced Osteolysis by Inhibiting Osteoclastogenesis and Inflammatory Response via the Suppression of TAK1 Activation
por: Meng, Jiahong, et al.
Publicado: (2018)

Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis
por: Li, Hui, et al.
Publicado: (2018)

Management of Periprosthetic Osteolysis after Total Ankle Arthroplasty
por: Park, Yoo Jung, et al.
Publicado: (2020)

Hip prosthetic loosening and periprosthetic osteolysis: A commentary
por: Mjöberg, Bengt
Publicado: (2022)

BNTA alleviates inflammatory osteolysis by the SOD mediated anti-oxidation and anti-inflammation effect on inhibiting osteoclastogenesis
por: Wang, Huidong, et al.
Publicado: (2022)

GPR84 potently inhibits osteoclastogenesis and alleviates osteolysis in bone metastasis of colorectal cancer
por: Jian, Li, et al.
Publicado: (2023)

MiR‐106b inhibition suppresses inflammatory bone destruction of wear debris‐induced periprosthetic osteolysis in rats
por: Yu, Binqing, et al.
Publicado: (2020)

Antibacterial mechanism of fraxetin against Staphylococcus aureus
por: WANG, HAITING, et al.
Publicado: (2014)

Effects of the Local Bone Renin-Angiotensin System on Titanium-Particle-Induced Periprosthetic Osteolysis
por: Zhao, Zhiping, et al.
Publicado: (2021)

Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB–NFATc1 signal pathway
por: Yang, Jing, et al.
Publicado: (2019)

Evidence for Gender-Specific Bone Loss Mechanisms in Periprosthetic Osteolysis
por: Ormsby, Renee T., et al.
Publicado: (2019)

Fraxetin alleviates microglia-mediated neuroinflammation after ischemic stroke
por: Deng, Shi-Ji, et al.
Publicado: (2022)

Conditional knockout of PDK1 in osteoclasts suppressed osteoclastogenesis and ameliorated prostate cancer-induced osteolysis in murine model
por: Zhang, Yanan, et al.
Publicado: (2023)

Fraxetin Inhibits the Proliferation and Metastasis of Glioma Cells by Inactivating JAK2/STAT3 Signaling
por: Qu, Liangchen, et al.
Publicado: (2021)

Effect of fraxetin on proliferation and apoptosis in breast cancer cells
por: Liu, Guodong, et al.
Publicado: (2017)

Magnoflorine Suppresses MAPK and NF-κB Signaling to Prevent Inflammatory Osteolysis Induced by Titanium Particles In Vivo and Osteoclastogenesis via RANKL In Vitro
por: Sun, Zhenyu, et al.
Publicado: (2020)

MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone
por: Wang, Ting, et al.
Publicado: (2015)

A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity
por: Chen, Yueqi, et al.
Publicado: (2020)

Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis
por: Schwarz, Edward M, et al.
Publicado: (2000)

Outcomes of Bone Graft for Periprosthetic Osteolysis after Total Ankle Arthroplasty
por: Park, Kwang Hwan, et al.
Publicado: (2022)

Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments
por: Li, Nianhu, et al.
Publicado: (2013)

Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway
por: Jie, Zhiwei, et al.
Publicado: (2022)

Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo
por: Chen, Shuai, et al.
Publicado: (2015)

20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways
por: Pan, Chenhao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bpbm364roq7og7khbgs5hgt0bf